A noninvasive treatment called high-intensity focused ultrasound helped relieve the shaking, stiffness and pain that ...

Researchers at the University of Pennsylvania have identified a protein that may play a central role in how Parkinson’s disease spreads through the brain. Their findings suggest that blocking this ...

Parkinson’s disease is a debilitating neurological condition that affects movement, causing tremors, stiffness and freezing episodes that can leave patients unable to move. Abou ...

An experimental gene-silencing therapy safely lowered LRRK2 protein levels in an early Parkinson’s trial, but its effect on ...

From special pens to earwax evaluations, a plethora of emerging diagnostics could one day be a major boon for people with the ...

Rebecca King Crews talks about how husband Terry first told her about a new FDA approval for focused ultrasound for treating Parkinson's Disease and what happened next.

Remepy, a pioneer in Hybrid Drugs™, today announced that the Phase IIa clinical trial of Hybridopa™, a new Hybrid Drug for Parkinson's disease, met its primary endpoint, delivering statistically ...

Investigational dopaminergic cell replacement therapy shows safety and preliminary motor improvements in early-phase Parkinson disease clinical trials.

An early start to treatment is crucial to successful therapy. A new sensor is helping with early detection. For the first ...

Biogen and Denali’s Parkinson’s disease drug failed to significantly slow disease progression in a Phase 2b study, missing ...

Analysis of microbes in the gut can reveal whether a person faces an elevated risk of Parkinson’s disease, before they have developed any symptoms, suggests a new study led by University College ...